{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:16:09Z","timestamp":1740028569011,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1124\/jpet.103.055236","type":"journal-article","created":{"date-parts":[[2003,11,27]],"date-time":"2003-11-27T01:18:50Z","timestamp":1069895930000},"page":"1001-1006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Renal Extraction of Angiotensin II"],"prefix":"10.1016","volume":"307","author":[{"given":"Edwin K.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Herzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.055236_bib1","doi-asserted-by":"crossref","unstructured":"Antonaccio MJ, Rubin B, Horovitz ZP, Laffan RJ, Goldberg ME, High JP, Harris DN, and Zaidi I (1979) Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats. Jpn J Pharmacol 29: 285\u2013294.","DOI":"10.1254\/jjp.29.285"},{"key":"10.1124\/jpet.103.055236_bib2","unstructured":"Arendshorst WJ, Chatziantoniou C, and Daniels FH (1990) Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int Suppl 30: S92\u2013S96."},{"key":"10.1124\/jpet.103.055236_bib3","doi-asserted-by":"crossref","unstructured":"Bauer J, Berthold H, Schaefer F, Ehmke H, and Parekh N (1999) Quantification of conversion and degradation of circulating angiotensin in rats. Am J Physiol 277: R412\u2013R418.","DOI":"10.1152\/ajpregu.1999.277.2.R412"},{"key":"10.1124\/jpet.103.055236_bib4","doi-asserted-by":"crossref","unstructured":"Biron P, Meyer P, and Panisset JC (1968) Removal of angiotensins from the systemic circulation. Can J Physiol Pharmacol 46: 175\u2013178.","DOI":"10.1139\/y68-029"},{"key":"10.1124\/jpet.103.055236_bib5","unstructured":"Blantz RC and Gabbai FB (1987) Effect of angiotensin II on glomerular hemodynamics and ultrafiltration coefficient. Kidney Int Suppl 20: S108\u2013S111."},{"key":"10.1124\/jpet.103.055236_bib6","doi-asserted-by":"crossref","unstructured":"Chatziantoniou C, Daniels FH, and Arendshorst WJ (1990) Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol 259: F372\u2013F382.","DOI":"10.1152\/ajprenal.1990.259.2.F372"},{"key":"10.1124\/jpet.103.055236_bib7","doi-asserted-by":"crossref","unstructured":"Chatziantoniou C, Ruan X, and Arendshorst WJ (1995) Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 92: 2924\u20132928.","DOI":"10.1073\/pnas.92.7.2924"},{"key":"10.1124\/jpet.103.055236_bib8","doi-asserted-by":"crossref","unstructured":"Edgley A, Kett M, and Anderson W (2001) `Slow pressor\u2019 hypertension from low-dose chronic angiotensin II infusion. Clin Exp Pharmacol Physiol 28: 1035\u20131039.","DOI":"10.1046\/j.1440-1681.2001.03590.x"},{"key":"10.1124\/jpet.103.055236_bib9","doi-asserted-by":"crossref","unstructured":"Gao L, Zhu C, and Jackson EK (2003) \u03b12-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 305: 581\u2013586.","DOI":"10.1124\/jpet.102.047647"},{"key":"10.1124\/jpet.103.055236_bib10","unstructured":"Granger JP and Schnackenberg CG (2000) Renal mechanisms of angiotensin II-induced hypertension. Semin Nephrol 20: 417\u2013425."},{"key":"10.1124\/jpet.103.055236_bib11","unstructured":"Hall JE, Brands MW, and Henegar JR (1999) Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 10: S258\u2013S265."},{"key":"10.1124\/jpet.103.055236_bib12","doi-asserted-by":"crossref","unstructured":"Hodge RL, Ng KK, and Vane JR (1967) Disappearance of angiotensin from the circulation of the dog. Nature (Lond) 215: 138\u2013141.","DOI":"10.1038\/215138a0"},{"key":"10.1124\/jpet.103.055236_bib13","doi-asserted-by":"crossref","unstructured":"Jackson EK (1994) Pertussis toxin normalizes enhanced renovascular responses to angiotensin II in spontaneously hypertensive rats. Life Sci 54: PL445\u2013PL450.","DOI":"10.1016\/0024-3205(94)90154-6"},{"key":"10.1124\/jpet.103.055236_bib14","doi-asserted-by":"crossref","unstructured":"Jackson EK and Herzer WA (2001) Regional vascular selectivity of angiotensin II. J Pharmacol Exp Ther 297: 736\u2013745.","DOI":"10.1016\/S0022-3565(24)29592-6"},{"key":"10.1124\/jpet.103.055236_bib15","doi-asserted-by":"crossref","unstructured":"Kawada N, Imai E, Karber A, Welch WJ, and Wilcox CS (2002) A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860\u20132868.","DOI":"10.1097\/01.ASN.0000035087.11758.ED"},{"key":"10.1124\/jpet.103.055236_bib16","doi-asserted-by":"crossref","unstructured":"Kost CK Jr, Herzer WA, Li P, and Jackson EK (1994) Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269: 82\u201388.","DOI":"10.1016\/S0022-3565(25)38713-6"},{"key":"10.1124\/jpet.103.055236_bib17","doi-asserted-by":"crossref","unstructured":"Kost CK Jr and Jackson EK (1993) Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension 21: 420\u2013431.","DOI":"10.1161\/01.HYP.21.4.420"},{"key":"10.1124\/jpet.103.055236_bib18","doi-asserted-by":"crossref","unstructured":"Li P and Jackson EK (1989) Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 251: 909\u2013921.","DOI":"10.1016\/S0022-3565(25)21097-7"},{"key":"10.1124\/jpet.103.055236_bib19","doi-asserted-by":"crossref","unstructured":"Melaragno MG and Fink GD (1995) Enhanced slow pressor effect of angiotensin II in two-kidney, one clip rats. Hypertension 25: 288\u2013293.","DOI":"10.1161\/01.HYP.25.2.288"},{"key":"10.1124\/jpet.103.055236_bib20","unstructured":"Mitchell KD and Navar LG (1990) Interactive effects of angiotensin II on renal hemodynamics and tubular reabsorptive function. Kidney Int Suppl 30: S69\u2013S73."},{"key":"10.1124\/jpet.103.055236_bib21","unstructured":"Motulsky HJ (1999) Fitting curves with nonlinear regression, in Analyzing Data with GraphPad Prism (Motulsky HJ ed) pp 199\u2013223, GraphPad Software, Inc., San Diego, CA."},{"key":"10.1124\/jpet.103.055236_bib22","unstructured":"Navar LG, Harrison-Bernard LM, Wang CT, Cervenka L, and Mitchell KD (1999) Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 10: S189\u2013S195."},{"key":"10.1124\/jpet.103.055236_bib23","doi-asserted-by":"crossref","unstructured":"Reams G, Villarreal D, and Bauer JH (1990) Intrarenal metabolism of angiotensin II. Am J Physiol 258: F1510\u2013F1515.","DOI":"10.1152\/ajprenal.1990.258.6.F1510"},{"key":"10.1124\/jpet.103.055236_bib24","doi-asserted-by":"crossref","unstructured":"Wagner C and Kurtz A (1998) Regulation of renal renin release. Curr Opin Nephrol Hypertens 7: 437\u2013441.","DOI":"10.1097\/00041552-199807000-00015"},{"key":"10.1124\/jpet.103.055236_bib25","doi-asserted-by":"crossref","unstructured":"Wood JM, Mah SC, and Schnell C (1990) Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition and angiotensin II antagonism in rats. J Cardiovasc Pharmacol 16: S60\u2013S64.","DOI":"10.1097\/00005344-199016004-00013"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524310481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524310481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.055236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:39:02Z","timestamp":1739975942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524310481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0022356524310481"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.055236","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Extraction of Angiotensin II","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.055236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}